Trial intelligence / Profile preview

Morphine vs Methadone for Cancer Pain

NCT00634010Phase 3Terminated

Sponsor
University of Texas MD Anderson Cancer Center
Start
Feb 2008
Primary completion
Jan 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methadone in cancer pain, sponsored by University of Texas MD Anderson Cancer Center. Started Feb 2008; status: terminated.

02

Drugs

methadone
03

Conditions

cancer pain

Beyond the preview

Go deeper on NCT00634010.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00634010.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call